Article Text

Download PDFPDF

Pulmonary vascular volumes and airways obstruction in SCD patients
  1. Anne Greenough1,2,
  2. Alan Lunt1,2
  1. 1 Division of Asthma, Allergy and Lung Biology, MRC-Asthma UK Centre in Allergic Mechanisms of Asthma, King's College London, London, UK
  2. 2 NIHR Biomedical Research Centre at Guy's and St Thomas’ NHS Foundation Trust and King's College London, London, UK
  1. Correspondence to Professor Anne Greenough, NICU, 4th Floor Golden Jubilee Wing, King's College Hospital, Denmark Hill, London SE5 9RS, UK; anne.greenough{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Dear Editor

We read with interest the recent paper by Chaudry et al 1 in which the authors describe an obstructive ventilatory defect in children with sickle cell disease (SCD) which was not linked to bronchial hyper-responsiveness, as assessed by methacholine challenge testing, or to eosinophillic inflammation. Their results further demonstrate that the airflow obstruction seen in children with SCD may not solely be due to asthma. Indeed, in children with SCD, we have shown that pulmonary capillary blood volume is increased compared to matched controls, and is correlated with airflow obstruction as assessed by impulse oscillometry.2 In SCD adults, we previously demonstrated that prominent central vessels were often present on high-resolution CT (HRCT) with correlations between reductions in FEV1 and FVC and prominence of central vessels.3 We have subsequently carried out a detailed study of vascular abnormalities on HRCT using two quantitative measures of vessel dilatation (the segmental artery-bronchus (A/B) ratio and the total cross-sectional area of all pulmonary vessels less than 5 mm in diameter (CSA<5 mm%). Increases in segmental A/B ratio and CSA<5 mm% were independently linked to reductions in FEV1, VC and FEF25–75, and to increased respiratory system resistance and RV:TLC. Small vessel dimensions correlated with reduced haemoglobin concentration and oxygen saturation and increased cardiac output, lactate dehydrogenase level, reticulocyte count and serum bilirubin, suggesting interactions between haemolysis, anaemia, hypoxia and pulmonary function abnormalities.4 We, therefore, suggest that alterations in pulmonary vascular volumes due to anaemia in SCD patients contribute to their lung function abnormalities.


View Abstract


  • Contributors AG and AL wrote the letter.

  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles